The Fidelity Select Biotechnology Portfolio (ticker: FSELX) is a mutual fund that invests in biotechnology companies. The fund's objective is to provide long-term capital appreciation by investing primarily in common stocks of companies that are involved in the research, development, and/or marketing of biotechnology products.
FSELX has a long history of strong performance. Over the past 10 years, the fund has returned an average of 12.2% per year, compared to 9.8% for the S&P 500 Index. The fund's 10-year return is also higher than the average return of its peer group, which is 11.1%.
FSELX is a relatively high-risk investment. The fund invests in a concentrated portfolio of biotechnology companies, which means that it is more volatile than the overall stock market. The fund's beta, which is a measure of volatility, is 1.24. This means that the fund is 24% more volatile than the S&P 500 Index.
FSELX invests in a variety of biotechnology companies, including companies that are developing new drugs, medical devices, and diagnostic tests. The fund's portfolio is managed by a team of experienced investment professionals who have a deep understanding of the biotechnology industry.
The fund's investment strategy is based on several key factors, including:
The fund's managers believe that by investing in companies with strong technology platforms, pipelines, management teams, and financial strength, they can generate long-term capital appreciation for their investors.
FSELX has an expense ratio of 0.75%. This means that for every $1,000 invested in the fund, $7.50 will be used to pay for the fund's operating expenses. The fund's expense ratio is higher than the average expense ratio of its peer group, which is 0.65%.
FSELX is a mutual fund, which means that it is subject to capital gains taxes. When the fund sells a stock, the proceeds are distributed to shareholders, who are then responsible for paying taxes on the gains. The fund's distributions are classified as either qualified or non-qualified. Qualified distributions are taxed at the capital gains rate, while non-qualified distributions are taxed at the ordinary income rate.
FSELX is a high-risk, high-reward investment. The fund has a long history of strong performance, but it is important to remember that past performance is not a guarantee of future results. The fund's high expense ratio and tax implications should also be considered before investing.
2024-11-17 01:53:44 UTC
2024-11-18 01:53:44 UTC
2024-11-19 01:53:51 UTC
2024-08-01 02:38:21 UTC
2024-07-18 07:41:36 UTC
2024-12-23 02:02:18 UTC
2024-11-16 01:53:42 UTC
2024-12-22 02:02:12 UTC
2024-12-20 02:02:07 UTC
2024-11-20 01:53:51 UTC
2024-12-22 20:22:08 UTC
2024-12-30 09:32:24 UTC
2024-12-21 11:03:16 UTC
2024-12-09 11:41:40 UTC
2024-12-15 04:53:59 UTC
2024-12-30 20:26:41 UTC
2024-12-07 06:21:41 UTC
2024-12-12 22:16:08 UTC
2025-01-04 06:15:36 UTC
2025-01-04 06:15:36 UTC
2025-01-04 06:15:36 UTC
2025-01-04 06:15:32 UTC
2025-01-04 06:15:32 UTC
2025-01-04 06:15:31 UTC
2025-01-04 06:15:28 UTC
2025-01-04 06:15:28 UTC